Watchmaker Genomics
Watchmaker Genomics is a Boulder, Colorado-based biotechnology company that engineers high-performance enzymes and integrated NGS workflow solutions for genomics research laboratories, clinical laboratories, and molecular diagnostics companies worldwide.
- Company typePrivate
- Founded2019
- HeadquartersBoulder, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Watchmaker Genomics does
Watchmaker Genomics is a Boulder, Colorado-based biotechnology company founded in 2019 that engineers high-performance enzymes and develops integrated next-generation sequencing (NGS) workflow solutions for genomics research, clinical laboratories, and molecular diagnostics companies. Its core technology platform is built on proprietary protein engineering that produces enzymes with enhanced thermostability, inhibitor tolerance, fidelity, and processivity, combined with novel method architectures including the EquiPlex CRISPR-Cas9-based library normalization technology and the TAPS/TAPS+ TET-assisted pyridine borane sequencing chemistry for combined genetic and epigenetic analysis. The product portfolio spans DNA and RNA library preparation kits, NGS library amplification master mixes (Equinox family), library normalization kits, a tiered StellarScript reverse transcriptase portfolio, DNA polymerases, and isothermal amplification (RPA) enzymes for point-of-care diagnostics.
The company operates a primarily B2B reagent and tools business model with three revenue streams: catalog sales of NGS reagent kits and precision enzymes (direct e-commerce with quote-based pricing), custom/OEM genomic solutions (white-label kitting, custom fills, and certificates of analysis for assay developers), and technology licensing (e.g., the TAPS alliance with Exact Sciences, the CRISPR-Cas9 license from Caribou Biosciences). Distribution combines direct enterprise field sales, a global distributor network, and OEM partnerships, supported by a heavy conference and event-driven go-to-market motion across ASHG, AGBT, ESCMID, AMP, ABRF, and ESHG. Watchmaker serves a horizontal customer base including core genomics facilities, translational and clinical labs (liquid biopsy, NIPT, oncology), and molecular diagnostics assay developers, with production-scale validation at named customers such as Hartwig Medical Foundation, UMC Utrecht, Nationwide Children's Hospital, and Broad Clinical Labs. The firm holds ISO 13485:2016 certification and is venture-backed following a $40 million Series A led by Decheng Capital in June 2022, with operating headcount in the 51-100 range.
Watchmaker Genomics firmographics
Firmographics- Name
- Watchmaker Genomics
- Legal name
- Watchmaker Genomics
- Website
- https://watchmakergenomics.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Watchmaker Genomics is a Boulder, Colorado-based biotechnology company that engineers high-performance enzymes and integrated NGS workflow solutions for genomics research laboratories, clinical laboratories, and molecular diagnostics companies worldwide.
- Ownership category
- akta.pro rank
Watchmaker Genomics industry classification
Industry- Product category
- Genomics Reagents and NGS Sample Preparation
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Watchmaker Genomics is headquartered
LocationHeadquarters
- HQ city
- Boulder
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Watchmaker Genomics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- NGS Reagent Sales: Sale of precision enzymes (reverse transcriptases, DNA polymerases, RNase inhibitors), library preparation kits (DNA and RNA), and amplification solutions to genomics research labs, clinical laboratories, and diagnostic companies.
- Custom/OEM Solutions: White-label kitting, custom formats, single-lot shipments, and custom certificates of analysis for assay developers and diagnostic companies requiring specialized reagent configurations.
- Technology Licensing: Licensing of proprietary technologies including TAPS to partners like Exact Sciences for commercialization in specific application areas.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard reagent kits and enzymes |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Watchmaker Genomics product offering
Product offeringCore offering
Watchmaker Genomics designs, manufactures, and sells precision enzymes, NGS library preparation kits (DNA, RNA, PCR-free, methylation), library amplification master mixes, reverse transcriptases, and isothermal amplification reagents for genomics research and clinical applications. The company also offers Custom Genomic Solutions (OEM kitting, custom fills, packaging, labeling) and licenses proprietary technologies such as TAPS to diagnostic partners.
Product overview
Watchmaker Genomics is a life sciences company developing a comprehensive portfolio of precision reagents and platforms for genomic research and clinical applications. The product portfolio spans DNA and RNA library preparation kits (including standard, fragmentation, and TAPS+ methyl-sequencing variants), NGS library amplification solutions (Equinox, Equinox Uracil-Tolerant, Equinox Prime), library normalization technologies (EquiPlex with CRISPR-based approach), reverse transcriptases (StellarScript portfolio with three thermostability tiers), DNA polymerases, and isothermal amplification enzymes (RPA). The company also offers custom genomic solutions for OEM customers. Key enabling technologies include TAPS (TET-assisted pyridine borane sequencing) for epigenetic analysis licensed from Exact Sciences, and CRISPR-Cas9 intellectual property from Caribou Biosciences for library normalization applications. Products target applications including liquid biopsy, whole genome sequencing, FFPE analysis, non-invasive prenatal testing, and infectious disease diagnostics.
Differentiator
Problem solved
Functional benefit
Products and services
- Watchmaker DNA Library Prep Kits DNA library preparation kits that increase conversion of template DNA into sequenceable library molecules to improve coverage and sequencing economy, especially with low-input liquid biopsy samples (cfDNA and ctDNA). Streamlined and automation-friendly workflow supports robust library preparation from fragmented DNA templates.
- Watchmaker DNA Library Prep Kit with Fragmentation DNA library preparation kit with integrated enzymatic DNA fragmentation, combining scalability and accuracy. Single-tube chemistry with reduced bias and artifacts, suited for PCR-free workflows, ultra-low inputs, and low-quality DNA samples including FFPE.
- Watchmaker DNA Library Prep Kits with TAPS+ DNA library preparation kits with TAPS+ technology enabling direct 5mC/5hmC sequencing for combined genetic and epigenetic analysis. Powers tumor profiling and liquid biopsy applications through multimodal insights.
- Watchmaker mRNA Library Prep Kits RNA library preparation kits featuring rapid workflow and sensitive mRNA detection. Designed for low-input and degraded samples including FFPE material.
- Equinox Library Amplification Kits NGS library amplification kits delivering ultra-high fidelity, low bias, and high-efficiency amplification across a wide input and GC-content range. Equinox Polymerase yields excellent fidelity, uniform sequence coverage, and high-complexity PCR products.
- Equinox Uracil-Tolerant Library Amplification Master Mix Uracil-tolerant amplification master mix for NGS library amplification with ultra-high fidelity and low bias. Supports methyl sequencing and other applications requiring uracil tolerance.
- EquiPlex Normalization Kit Novel CRISPR-Cas9-based library normalization kit that simplifies library pooling at scale. Repurposes Cas9 as a stoichiometric molecular binding tool rather than cutting enzyme, capturing fixed numbers of molecules from each library regardless of starting concentration.
- Equinox Prime Library Amplification Master Mix Next-generation amplification solution engineered to reduce polymerase slippage in homopolymer and repetitive genomic regions prone to indel artifacts. Designed to improve variant calling accuracy in somatic oncology workflows including MSI profiling, while delivering low error rates, high library yields, and uniform GC coverage across WGS, WES, and other sequencing applications.
- StellarScript Reverse Transcriptase Portfolio Family of engineered M-MLV reverse transcriptase variants (StellarScript, StellarScript HT, StellarScript HT+) with reduced RNase H activity, enhanced processivity, activity, thermostability (up to 42-65°C in HT+), and inhibitor tolerance. Suitable for cDNA synthesis, RNA-seq, and point-of-care testing.
- Stellar RT-qPCR and qPCR Kits RT-qPCR and qPCR kits engineered for extreme inhibitor tolerance, speed, and sensitivity. Enable extraction-free amplification and results in minutes from a range of sample types for molecular diagnostics applications.
- StellarTaq DNA Polymerase DNA polymerase engineered for extreme inhibitor tolerance, speed, and specificity. Available in hot start, non-hot start, and glycerol-free formats for qPCR applications with challenging sample types.
- RNase Inhibitor RNase inhibitor that protects RNA from degradation at temperatures up to 55°C. High-purity enzyme suited for single-cell, single-nuclei sequencing, and pathogen detection applications.
- Recombinase Polymerase Amplification (RPA) Enzymes Isothermal amplification enzyme kit including T4 UvsX DNA Recombinase, T4 UvsY Protein, T4 Gene 32 Protein, and Bsu DNA Polymerase Large Fragment. Enables rapid, field-deployable molecular assays with lower amplification temperatures than LAMP.
- Whole Genome Sequencing Solutions Comprehensive whole genome sequencing portfolio including PCR-free library prep, enzymatic fragmentation, and compatibility with various sequencing platforms. Designed for applications including de novo sequencing, low-pass WGS, and human resequencing for inherited and rare diseases.
- Custom Genomic Solutions Custom OEM capabilities including flexible fills, packaging, labeling (including white and private label), and custom certificates of analysis. Designed for developers of cutting-edge technologies requiring enzymes and reagents at scale.
- Callisto Complete Kit for DNA EF Library Prep (with Volta Labs) Jointly developed with Volta Labs, combining Watchmaker's NGS sample preparation chemistry with Volta's digital fluidics automation to deliver a fully automated, PCR-free whole genome sequencing library preparation workflow for clinical and translational research laboratories.
Quantifiable outcome
- 9-fold higher library yields with cfDNA compared to competing kits
- +5 more outcomes
Companies that use Watchmaker Genomics
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles3 records
Watchmaker Genomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature8 records
Watchmaker Genomics partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- Volta LabscoreLaunched Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026, combining Watchmaker's NGS sample preparation chemistry with Volta's digital fluidics automation platform for fully automated, PCR-free whole genome sequencing workflows targeting clinical and translational research laboratories.
- Caribou BiosciencescoreNon-exclusive license for foundational CRISPR-Cas9 intellectual property for use in next-generation sequencing library preparation. Technology serves as programmable binding tool for NGS library normalization and PCR-free WGS applications including population genomics, newborn screening, and rare disease diagnostics.
- Visby MedicalcoreStrategic collaboration to develop next-generation diagnostic tests for respiratory pathogen detection in at-home setting. Combines Visby's instrument-free PCR testing technology with Watchmaker's StellarScript HT+ Reverse Transcriptase enzyme engineered for inhibitor tolerance in unprocessed clinical samples.
- SPT LabtechcorePartnership to simplify and streamline NGS library preparation through integration of Watchmaker's library prep solutions with SPT Labtech's automated instrumentation and consumables for life science applications.
- Beckman Coulter Life SciencescoreCollaboration to deliver NGS library preparation solutions combining Watchmaker's library prep chemistry with Beckman's automated liquid handling solutions to enable labs to streamline operations and generate consistent results.
- Exact SciencescoreTAPS Technology License and Supply Alliance for commercializing TAPS (TET-assisted pyridine borane sequencing) technology for high-accuracy genomic DNA methylation analysis. Supports liquid biopsy-based cancer detection and epigenetic biomarker identification applications.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Watchmaker Genomics competitors and assessment
Company assessmentDirect peers
- New England Biolabs: Privately held manufacturer of enzymes and reagents for genomics, including DNA polymerases, ligases, and library prep kits. Directly comparable to Watchmaker across its precision enzyme portfolio and NGS reagent catalog, with a much broader catalog and deeper install base.
- Roche (KAPA Biosystems): Roche acquired KAPA Biosystems, a direct competitor in NGS library prep enzymes and kits. KAPA's hyperactive polymerases and library prep reagents compete head-to-head with Watchmaker's Equinox and DNA library prep kits in the same core labs and clinical sequencing customers.
- 10x Genomics: Public NGS tools company offering single-cell and spatial library prep kits plus Chromium instrumentation. Competes with Watchmaker in the RNA-seq and single-cell library prep reagent market and increasingly in workflow automation.
- Twist Bioscience: Public synthetic DNA and NGS target enrichment company with a growing library prep and enzymatic reagent portfolio. Closely comparable as a DNA-synthesis-rooted tools company expanding into NGS sample prep chemistries.
Broad incumbents
- Illumina: Dominant NGS platform vendor that also sells library prep reagents (e.g., DNA Prep, RNA Prep with Enrichment) bundled with its sequencing instruments. Indirect reagent competitor but the dominant channel through which many of Watchmaker's customers sequence.
- Qiagen: Global sample-prep and molecular diagnostics reagent vendor with broad kits for DNA/RNA extraction, library prep, and PCR. Overlaps with Watchmaker's MDx tools and OEM enzyme business, particularly in clinical and translational customers.
- Agilent Technologies: Large analytical instruments and life-sciences reagents vendor covering genomics, cell analysis, and diagnostics. Competes in selected library prep, NGS QC, and OEM reagent categories for clinical and translational genomics customers.
- Bio-Rad Laboratories: Life science tools and clinical diagnostics company with a ddPCR and digital biology franchise. Competes with Watchmaker in qPCR reagents (StellarTaq/Stellar RT-qPCR) and OEM enzyme supply to diagnostics developers.
- Revvity (formerly PerkinElmer Life Sciences): Life sciences and diagnostics vendor offering reagents, automation, and OEM services for genomics and cell biology. Comparable as a broader reagent-and-OEM incumbent serving translational and clinical genomics customers.
Emerging players
- Diagenode: Epigenetics and methylation tools company (now part of Hologic) offering bisulfite conversion kits and methylation analysis reagents. Directly comparable to Watchmaker's TAPS/TAPS+ methylation sequencing franchise, though smaller and more niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Watchmaker Genomics social profiles
Digital presenceWatchmaker Genomics compliance and trust
Trust signalCompliance1 record
Watchmaker Genomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Watchmaker Genomics leadership team
Management profileNumber of profiles
Profiles10 records
Watchmaker Genomics funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Watchmaker Genomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Watchmaker Genomics
What does Watchmaker Genomics do?
Watchmaker Genomics designs, manufactures, and sells precision enzymes, NGS library preparation kits (DNA, RNA, PCR-free, methylation), library amplification master mixes, reverse transcriptases, and isothermal amplification reagents for genomics research and clinical applications. The company also offers Custom Genomic Solutions (OEM kitting, custom fills, packaging, labeling) and licenses proprietary technologies such as TAPS to diagnostic partners.
Is Watchmaker Genomics a public or private company?
Watchmaker Genomics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Watchmaker Genomics founded?
Watchmaker Genomics was founded in 2019. It employs 51 to 100 people.
Where is Watchmaker Genomics based?
Watchmaker Genomics is headquartered in Boulder, United States, in the North America region.
How does Watchmaker Genomics make money?
Three revenue lines are on record. NGS Reagent Sales are the primary driver. The others are custom/OEM Solutions and technology Licensing.
Who are Watchmaker Genomics's main competitors?
Direct peers on record are New England Biolabs, Roche (KAPA Biosystems), 10x Genomics and Twist Bioscience. Broad incumbents are Illumina, Qiagen, Agilent Technologies, Bio-Rad Laboratories and Revvity (formerly PerkinElmer Life Sciences). Diagenode is listed as an emerging player.
Does Watchmaker Genomics have an API?
No public API is recorded for Watchmaker Genomics.
What industry is Watchmaker Genomics in?
Watchmaker Genomics's product category is Genomics Reagents and NGS Sample Preparation. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 334516 and its SIC code is 3826.